Skip to content
ClinCalc Pro
Menu
Topical ophthalmic combination (steroid + aminoglycoside + polypeptide)

Dexamethasone with hypromellose, neomycin and polymyxin B sulfate

Brand names: Maxitrol

This is a combined ophthalmic preparation containing the corticosteroid dexamethasone, the lubricant hypromellose, and the antibiotics neomycin and polymyxin B sulfate, used for ocular surface inflammation where a bacterial infection is present or likely.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Dexamethasone suppresses ocular inflammation by inhibiting inflammatory mediators; neomycin (an aminoglycoside) and polymyxin B provide broad Gram-negative and some Gram-positive antibacterial cover, while hypromellose lubricates and prolongs contact time.

Prescribing in practice

  • Topical corticosteroids must not be used in undiagnosed red eye or suspected herpes simplex (dendritic) keratitis, where they can cause rapid corneal melting and sight loss, so a herpetic cause must be excluded.
  • Prolonged use risks steroid-induced glaucoma, cataract and masking or worsening of infection, so courses should be short and ophthalmologist-supervised.
  • Neomycin is a frequent cause of contact hypersensitivity; discontinue if local allergic reaction develops.

Monitoring

With more than short-term use, monitor intraocular pressure and review the cornea and clinical response, stopping if infection worsens or hypersensitivity appears.

Counselling the patient

  • Use only for the prescribed short course and do not keep using it for future eye problems.
  • Stop and seek advice if the eye becomes more painful, red or swollen, which may indicate an allergy or worsening infection.
  • Remove contact lenses during treatment unless your clinician advises otherwise.

Evidence & guidelines

Combined steroid-antibiotic eye preparations are well established for inflammatory eye conditions with a bacterial component, with safe use depending on excluding viral keratitis and limiting duration.

Reference: RCOphth; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.